Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_89d397e2fff9dece10c981cc12cb9f06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7008 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7008 |
filingDate |
2004-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99671c60216e5b99d0082302067a0d75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23fcf56b0ef4c9babdbdc23593c7a0b0 |
publicationDate |
2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1570842-A2 |
titleOfInvention |
Composition containing chondroitin sulphate |
abstract |
The present invention concerns new chondroitin sulfate compositions with a twofold therapeutic action. The new compositions of the invention are characterised by a high patient compliance, being extremely useful for prolonged therapy. To achieve these aims, the new compositions contain primary and secondary structuring agents, as well as defined amounts of water for predissolving the active principle contained therein. <IMAGE> |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2936712-A1 |
priorityDate |
2003-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |